ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
-0,01%
Bitcoin
104.629,30
-0,21%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. SIGA Technologies Inc (SIGA)

  7. SIGA Technologies Inc (SIGA) News

SIGA

SIGA Technologies (SIGA)

SIGA Technologies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SIGA
DatumZeitQuelleÜberschriftSymbolFirma
02/01/202513h30GlobeNewswire Inc.TEPOXX (tecovirimat) Approved in Japan for the Treatment of OrthopoxvirusesNASDAQ:SIGASIGA Technologies Inc
13/12/202422h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
10/12/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
10/12/202422h00GlobeNewswire Inc.Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedNASDAQ:SIGASIGA Technologies Inc
08/11/202423h31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SIGASIGA Technologies Inc
07/11/202422h55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SIGASIGA Technologies Inc
07/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
07/11/202422h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024NASDAQ:SIGASIGA Technologies Inc
31/10/202412h30GlobeNewswire Inc.SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
29/10/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
24/10/202420h02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SIGASIGA Technologies Inc
22/10/202413h30GlobeNewswire Inc.SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal AntibodiesNASDAQ:SIGASIGA Technologies Inc
08/10/202413h30GlobeNewswire Inc.SIGA Announces Agreement to Supply TPOXX® in MoroccoNASDAQ:SIGASIGA Technologies Inc
04/10/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
23/09/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
20/09/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
21/08/202422h00GlobeNewswire Inc.SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®NASDAQ:SIGASIGA Technologies Inc
15/08/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
15/08/202413h35GlobeNewswire Inc.Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox ReleasedNASDAQ:SIGASIGA Technologies Inc
01/08/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SIGASIGA Technologies Inc
01/08/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
01/08/202422h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024NASDAQ:SIGASIGA Technologies Inc
25/07/202413h30GlobeNewswire Inc.SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
19/07/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
19/07/202414h00GlobeNewswire Inc.SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®NASDAQ:SIGASIGA Technologies Inc
17/06/202422h05GlobeNewswire Inc.SIGA Announces Agreement to Sell TPOXX® to ASEAN Member StatesNASDAQ:SIGASIGA Technologies Inc
13/06/202422h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
13/06/202422h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
13/06/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
13/06/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:SIGA

Kürzlich von Ihnen besucht

USOTC
BNPQY
BNP Paribas (QX)
CCOM
US500
US 500
DBI
MDAX
MDAX
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
FX
EURJPY
Euro vs Yen
NASDAQ
TSLA
Tesla
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
TG
RHM
Rheinmetall
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
COIN
AVAXUSD
Avalanche
NASDAQ
NVDA
NVIDIA
TG
NOV
Novo Nordisk
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten